(Sabic) -- SABIC’s Innovative Plastics
business announced that its manufacturing facilities in Campinas, Brazil and
Tortuguitas, Argentina, are now certified to produce U.S. Food and Drug
Administration (FDA) - compliant and biocompatible resins for the fast-growing
South American healthcare market to help slash lead times, reduce inventory
costs and increase flexibility in material purchasing.

Medical markets in eight Latin and South American countries - Brazil,
Mexico, Argentina, Chile, Venezuela, Peru, Colombia and Cuba - are expected
to demonstrate a compound annual growth rate (CAGR) of 4.6 percent between 2008
and 2013, reaching U.S. USD9.2 billion, according to Espicom Health
Intelligence.

To meet this increasing demand, SABIC is committed to providing local
customers fast and easy access to high-performance materials - such as
biocompatible Lexan HP polycarbonate (PC) resins - and technical resources
that they need to bring the next generation of medical applications to
market.